Phase 4
Completed N=233
Lidocaine Jelly for Pain Control During Mohs Surgery
Postoperative Pain · Satisfaction, Consumer
Source: ClinicalTrials.gov NCT03595449 ↗
Enrolled (actual)
233
Serious AEs
0.0%
Results posted
Jun 2021
Primary outcomePrimary: Mean Change in Patient Perception of Pain Score — 0.5; 0.3 score on a scale
◆ Published Evidence
No publication linked
No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.
Summary
Does the use of lidocaine jelly during Mohs surgery on the nose decrease the total amount of lidocaine used during surgery.
Does patient satisfaction improve when lidocaine jelly is used during Mohs surgery of the nose?
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Mean Change in Patient Perception of Pain Score |
0.5; 0.3 | — |
| SECONDARY Mean Total Amount of Intervention (Lidocaine or Surgilube) Used |
28.1; 24.4 | — |
Eligibility Criteria
Inclusion criteria
Patients having Mohs surgery on the nose who are able to consent to the study >18 years old
Exclusion criteria
unable to consent for themselves known allergy to lidocaine Mohs surgery in locations other than the nose
Data sourced from ClinicalTrials.gov (NCT03595449). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.